16-29813563-TTCTG-T
Position:
Variant summary
Our verdict is Pathogenic. Variant got 12 ACMG points: 12P and 0B. PVS1PM2PP5_Moderate
The NM_145239.3(PRRT2):c.514_517delTCTG(p.Ser172fs) variant causes a frameshift change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Pathogenic (★). Variant results in nonsense mediated mRNA decay.
Frequency
Genomes: not found (cov: 31)
Consequence
PRRT2
NM_145239.3 frameshift
NM_145239.3 frameshift
Scores
Not classified
Clinical Significance
Conservation
PhyloP100: 0.212
Genes affected
PRRT2 (HGNC:30500): (proline rich transmembrane protein 2) This gene encodes a transmembrane protein containing a proline-rich domain in its N-terminal half. Studies in mice suggest that it is predominantly expressed in brain and spinal cord in embryonic and postnatal stages. Mutations in this gene are associated with episodic kinesigenic dyskinesia-1. Alternatively spliced transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Jan 2012]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Pathogenic. Variant got 12 ACMG points.
PVS1
Loss of function variant, product undergoes nonsense mediated mRNA decay. LoF is a known mechanism of disease.
PM2
Very rare variant in population databases, with high coverage;
PP5
Variant 16-29813563-TTCTG-T is Pathogenic according to our data. Variant chr16-29813563-TTCTG-T is described in ClinVar as [Pathogenic]. Clinvar id is 31169.Status of the report is criteria_provided_single_submitter, 1 stars. Variant chr16-29813563-TTCTG-T is described in Lovd as [Pathogenic].
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PRRT2 | NM_145239.3 | c.514_517delTCTG | p.Ser172fs | frameshift_variant | 2/4 | ENST00000358758.12 | NP_660282.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PRRT2 | ENST00000358758.12 | c.514_517delTCTG | p.Ser172fs | frameshift_variant | 2/4 | 1 | NM_145239.3 | ENSP00000351608.7 | ||
ENSG00000280893 | ENST00000609618.2 | n.514_517delTCTG | non_coding_transcript_exon_variant | 2/6 | 5 | ENSP00000476774.2 |
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD3 genomes
Cov.:
31
We have no GnomAD4 exomes data on this position. Probably position not covered by the project.
GnomAD4 genome Cov.: 31
GnomAD4 genome
Cov.:
31
Bravo
AF:
ClinVar
Significance: Pathogenic
Submissions summary: Pathogenic:2
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
Episodic kinesigenic dyskinesia 1 Pathogenic:1
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 20, 2011 | - - |
Episodic kinesigenic dyskinesia Pathogenic:1
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Oct 13, 2022 | This premature translational stop signal has been observed in individual(s) with paroxysmal kinesigenic dyskinesia (PMID: 22101681). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Ser172Argfs*3) in the PRRT2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PRRT2 are known to be pathogenic (PMID: 22623405, 22744660). ClinVar contains an entry for this variant (Variation ID: 31169). For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at